Skip to content

Shenfu Injection for Postoperative Delirium (SFI for POD)

POD and Postoperative Outcomes in Senile Patients After SFI for Hip Fracture Surgery: A Randomized Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05179252
Acronym
POD
Enrollment
350
Registered
2022-01-05
Start date
2022-02-01
Completion date
2022-12-01
Last updated
2022-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Delirium

Brief summary

Surgery or trauma may cause serious problem to patients, especially for senile ones, like postoperative delirium or more postoperative complications. Here, we conduct a investigation of SFI for preventing the happening of POD or postoperative complications.

Detailed description

SFI(Shenfu Injection), a historical medical herbal medicine of traditional Chinese, which may produced much benefit to clinical patients with furtigue after major surgery, because it was a comment sense to think of energy loss if they experience surgical damage. Here, we administrated intravenously SFI into senile patients, who receiving hip fracture surgery, to avoid bad results or serious postoperative outcomes, in case of enhancing recovery after surgery.

Interventions

DRUGShen-Fu injection

Chinese patent medicine made by modern technology

DRUGnormal saline

0.9% normal saline, used for sham control

Sponsors

Shandong Institute of Science and Technology Information
CollaboratorOTHER
Shandong University of Traditional Chinese Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
75 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* hip fracture surgery under epidural anesthesia

Exclusion criteria

* Severe dementia, hearing/vision impairment, coma, etc., unable to communicate; * patients with end-stage diseases such as tumor; * 3 months after myocardial infarction, cerebral infarction; * severe heart, liver and renal dysfunction.

Design outcomes

Primary

MeasureTime frameDescription
incidence of postoperative delirium within 7 daysday 1-7 after surgery, more scores means higher incidence of PODpostoperative delirium(POD), assessed with Confusion Assessment Method scale and Richmond Agitation-Sedation Scale together.

Secondary

MeasureTime frameDescription
length of stayapproximately day 1 in hospital to day 7length of hospital stay
pain assessment within 3 daysday 1-3 after surgery, higher scores mean more pain.postoperative pain estimated with Numerical Rating Scale
non-delirium complicationsday 1-7 after surgerypostoperative complications except for delirium
survival in 1 year1 year discharge from hospitallong-term follow up
adverse events to shenfu injectionapproximately day1-7 after surgeryadverse events caused form shenfu injection
all-caused mortality within 30 days30 days after surgeryshort-term follow up

Contacts

Primary Contactzhang weiliang
hezhangweiliang@163.com13365316885
Backup Contactzhang xin
0531-68616733

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026